Thermo Fisher Scientific (NYSE:TMO) reported third-quarter revenue growth of 9% to $12.14 billion, supported by 6% organic growth, acquisitions and foreign-exchange effects. Adjusted earnings per share rose 15% to $6.68, while adjusted operating income increased 15% to $2.97 billion.
Chairman and C
(Teleborsa) - Thermo Fisher Scientific, a U.S. multinational company active in the field of life sciences and services for scientific research, closed the third quarter of 2026 with revenues...